EMGLIF-LM XR 12.5/2.5/1000MG 28S TAB

Emglif-LM XR 12.5/2.5/1000mg Tablet is an extended-release combination antidiabetic medicine containing Empagliflozin, Linagliptin, and Metformin. It is used to control high blood sugar levels in adults with Type 2 Diabetes Mellitus. This advanced triple therapy works by reducing sugar absorption in the intestines, improving insulin sensitivity, and promoting glucose excretion through urine, helping to achieve stable and long-term glycemic control.

Uses:

• Effectively manages Type 2 Diabetes Mellitus

• Lowers blood glucose and HbA1c levels

• Supports weight reduction and cardiovascular health

• Enhances insulin activity and decreases sugar production in the liver

• Used as part of a comprehensive diabetes management plan with diet and exercise

Benefits:

• Triple combination therapy for improved glucose control

• Extended-release (XR) formula ensures all-day blood sugar stability

• Reduces the risk of diabetic complications related to heart and kidneys

• Once-daily dosage for convenience and better compliance

• May contribute to weight loss and improved energy levels

Possible Side Effects:

• Frequent urination or mild dehydration

• Nausea, stomach upset, or diarrhea (due to Metformin)

• Genital or urinary tract infections (from glucose excretion)

• Dizziness or fatigue in rare cases

• Seek medical advice if symptoms persist or worsen